SUMMARY In helically cut strips of dog cerebral, coronary, mesenteric and femoral arteries, the contractile response to prostaglandin (PG) F 2( , and E 2 , relative to contractions induced by 30 mM K + , did not appreciably differ, whereas relaxations induced by PGE, relative to those induced by 10 * M papaverine were significantly different; the least in cerebral arteries and the greatest in mesenteric arteries. The relaxation of human cerebral arteries in response to PGE, was similar to that of dog cerebral arteries. Treatment for 60 min with polyphloretin phosphate (3 X 10" and 10 ' g/ml) suppressed the contractile response to PGF 2( , and E 2 but did not alter the response to 25 mM K + . The relaxing effect of PGE, was not influenced. Aspirin (5 X 10" and 2 X 10 ' M) significantly potentiated the contractile response to PGF to and E 2 but did not alter the relaxation induced by PGE,. In contrast, contractions induced by serotonin were attenuated. It is concluded that dog cerebral, coronary, mesenteric and femoral arteries relaxed differently in response to PGE,. It appears that arterial responses to vasoconstricting PCs, but not to the vasodilating PG, are significantly attenuated by polyphloretin phosphate and potentiated by aspirin.
PROSTAGLANDINS (PGs) induce changes in systemic blood pressure, regional blood flow and tone of vascular smooth muscle. Alterations induced by a variety of PG derivatives differ markedly, and even the same PGs sometimes elicit opposite actions on vessels from various species. Different responses of cerebral vessels to PGEi and E 2 have been reported, 16 however, it is generally agreed that PGF 2a causes constriction in cerebral vessels.
The ability of polyphloretin phosphate (PPP) to antagonize the effect of PGE 2 on intraocular pressure was first demonstrated by Beitch and Eakins. 7 PPP does not antagonize all actions of PGs on uterine, tracheal and bronchial smooth muscles. 8 " 10 Aspirinlike anti-inflammatory agents inhibit the biosynthesis of PGs in isolated tissues and whole animals, 11 ' 12 but the interaction between PGs and aspirin or indomethacin, related to responses of vascular smooth muscles, has not been clarified.
The present study was undertaken to compare the actions of PGE,, E 2 and F 2a on isolated dog cerebral arteries with their actions on coronary, mesenteric and femoral arteries and to analyze the antagonistic action of PPP in these arteries. Alterations in the response of the arteries to PGs after aspirin and indomethacin application were also investigated.
Methods
Mongrel dogs of both sexes, weighing 7 to 15 kg, were anesthetized with intraperitoneal injections of sodium pentobarbital in a dose of 50 mg/kg and sacrificed by bleeding from common carotid arteries. The brain and heart were rapidly removed. Basilar and middle cerebral arteries (0.5 to 0.8 mm outside diameter) and ventral interventricular branches of the left coronary artery (0.6 to 0.9 mm) were isolated.
Distal portions of the mesenteric (0.5 to 0.8 mm) and femoral arteries (0.5 to 0.8 mm) were also removed. The arteries were helically cut into strips, the length being approximately 20 mm. The specimen was vertically fixed between hooks in a muscle bath containing nutrient solution, which was maintained at 37 ± 0.5°C and aerated with a mixture of 95% O 2 and 5% CO 2 . Hooks anchoring the upper end of the strips were connected to the lever of a force-displacement transducer (Nihonkoden Kogyo Co., Tokyo, Japan). The resting tension was adjusted to 1.5 g, which was determined to be optimal for obtaining maximum contraction. 13 u Composition of the nutrient solution was (mM): Na + , 162.1; K \ 5.4; Ca ++ , 2.2; M g + \ 1.0; Cl", 159.0; HCOy, 14.9 and dextrose, 5.6. The pH of the solution was 7.2 to 7.3. Osmotic adjustment was not made when K + (up to 30 mM) was added to the bathing media. Before the start of experiments, all preparations were allowed to equilibrate for 90 to 120 min in the control media during which time the fluids were replaced every 15 to 20 min.
Seven human cerebral arteries (4 intracranial internal carotid and 3 basilar) were obtained during autopsy from 4 humans, 50-, 61-, 65-and 81-year-old males, within 8 hours after death. The causes of death were lung cancer, peritoneal carcinomatosis, and urinary bladder cancer. Human arteries were cut into helical strips, which were fixed at a resting tension of 2 g in the bathing media, as described above.
Isometric contractions and relaxations were recorded on an ink-writing oscillograph (Sanei Sokki Co., Tokyo, Japan). The contractile response to 30 mM K + was first obtained. PGs and serotonin were added directly to the bathing media in cumulative concentrations, and contractions relative to those induced by 30 mM K + are presented. Arterial strips were contracted with either PGF 2a or K + before the addition of PGE,. Relaxations induced by 10~4 M papaverine were taken as 100% and relaxations induced by PGEj relative to papaverine-induced relaxations are CEREBROARTERIAL RESPONSE TO PROSTAGLANDINS/Forfa et al.
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presented. Preparations were exposed for 60 min to PPP or for 20 min to other blocking agents, before the dose-response curve of PGs was obtained. Results shown in the text and figures represent mean values ± standard errors of the means. Statistical analyses were made using the Student's r-test. Drugs used were PGA^ A 2 , Ej, E 2 and F 2a (Ono Co., Osaka, Japan), serotonin creatinine sulfate, acetyl salycylic acid (aspirin), indomethacin, sodium polyphloretin phosphate (PPP), chlorpheniramine maleate, phentolamine mesylate, methysergide bimaleate, dlpropranolol hydrochloride, atropine sulfate, cimetidine, aminophylline and papaverine hydrochloride.
Results

Responses of Different Arteries to PGs
In helically cut strips of dog cerebral, coronary, mesenteric and femoral arteries, the addition of PGF 2a in concentrations ranging from IO 7 to 10~6 M caused a dose-related contraction ( fig. 1, left) . was observed in response to 2 X 10~8 and 10' M PGF 2tt . In the remaining preparations, even though contracted with serotonin or K + , no relaxation was obtained.
The addition of PGEj (2 X 10" 8 to 10' 5 M) also elicited dose-dependent contractions; the maximum contraction was attained at 10~5 M ( fig. 1, right) . Dose-response relationships in cerebral, coronary, mesenteric and femoral arteries were similar, although the highest concentration of PGE 2 (10~5 M) produced greater contractions in femoral than in cerebral arteries (P < 0.02).
In 2 human cerebral arteries, PGF 2a and E 2 produced a dose-related contraction.
PGA, and A 2 (10~7 to 10~5 M) caused contractions in isolated dog cerebral, coronary and mesenteric arteries. An increase in the concentration to 5 X 10~6 M caused additional contractions in mesenteric and slight contractions in the other arteries.
The relaxation induced by PGE, was significantly greater in mesenteric than in cerebral arteries. The relaxing effect on cerebral arteries did not differ in basilar and middle cerebral arteries. The average relaxations induced by 5 X 10 7 , 2 X 10" 6 and lO" 6 M PGE, were 15.9 ± 4.1, 41.1 ± 4.6 and 56.7 ± 4.9%, respectively (N = 18), in basilar arteries, and 12.9 ± 7.5, 51.1 ± 5.4 and 61.1 ± 5.8%, respectively (N = 8), in middle cerebral arteries. Similar dosedependent relaxations were observed in human cerebral arteries contracted with PGF 2a (fig. 2 ). In 7 out of 24 cerebral and 11 out of 23 coronary arteries, slight but significant contractions were produced at low concentrations (2 X 10 8 and 10"' M) of PGE,. In contrast, such contractions were not observed in mesenteric and femoral arteries.
Relaxation in response to PGE, was also found in coronary arteries contracted with K + (10 to 15 mM). However, in the K + -contracted arteries, contractions seen at low concentrations of PGEj were greater and relaxations at high concentrations were significantly less, as compared with those in PGF 2a -contracted arteries ( fig. 2, right) . Similar results were observed in 3 cerebral and 2 mesenteric arteries. 5 ). The attenuation with PGE 2 was greater than that for PGF 2a . The inhibition was reversed only partially by repeated washing of the preparations. PPP in a concentration of 3 X 10' 5 g/ml did not alter the contractile response of cerebral arteries to 25 mM K + but at 10~4 g/ml significantly attenuated the response ( fig.  6 ).
Contraction induced by low concentrations of PGE, (2 X 10" and 10' M) in coronary arteries, contracted with K + , was unaffected by PPP (10 4 g/ml). Relaxation induced by PGE, in coronary and mesenteric arterial strips in concentrations ranging from 2 X 10" to 2 X 10" 6 M was not affected by PPP, while the response to 10' 5 M PGE! was potentiated ( fig. 7 ).
Modification by Aspirin of Response to PGs
Contractile responses of cerebral arteries to PGF 2o and E 2 were significantly potentiated by treatment for 20 min with aspirin (5 X 10 5 and 2 X 10" 4 M). This potentiation was reversed by repeated replacement of aspirin-added solutions with control fluids (fig. 8) . Similar potentiation was observed in mesenteric arterial strips treated with aspirin. Contractions at 2 X 10-" and 10 6 M PGF 2a were 61.2 ± 10.7% and 100% (1823 ± 213 mg, N = 6), respectively, in control preparations, and 106.7 ± 17.4% and 149.8 ± 20.0%, respectively, in aspirin (2 X 10 4 M)-treated preparations. Indomethacin (10~6 M) was also effective in potentiating the response to PGF 2a and E 2 . Treatment with aspirin in concentrations of 5 X 10~5 and 2 X 10~4 failed to alter significantly the contractile response of cerebral arteries to 25 mM K + , but attenuated the response to serotonin in a dosedependent manner ( fig. 9 ).
Treatment with 2 X 10~4 M aspirin did not influence the relaxing effect of PGE, in cerebral and mesenteric arterial strips contracted with PGF 2a ( fig. 10) cerebral arteries, while PGEj elicited relaxations. Similar results with PGE! and E 2 were observed in isolated dog coronary and mesenteric arteries. 16 It has been demonstrated that cerebral vessels are constricted by PGF 2a when applied intraarterially, intravenously or topically to basilar and pial arteries. cerning the cerebrovascular effect of PGE! and E 2 . PGE 2 injected intraarterially or intravenously causes cerebral vasodilatation in dogs and cats 4 -6 but when applied topically causes vasoconstriction in cats. 6 Yamamoto et al. 1 have demonstrated that PGE, decreases cerebral blood flow in dogs, but Steiner et al. 2 and Nakano et al. 4 found the opposite in humans and dogs. Allen et al. 17 have shown a PGE,-induced contraction of isolated cerebral arterial segments from humans and dogs, while the present study demonstrated marked relaxation of dog as well as human cerebral arteries in response to PGE^ Such an inconsistency in the response of cerebral vessels to PGE, is not believed to be due to species difference but possibly to the ability of PGEi to induce both contraction and relaxation. In approximately one-third of the cerebral arterial preparations, PGE, in low concentrations induced slight but significant contractions. At the highest concentration used (10~5 M), contractile • Control ( 7) O PPP I0" 4 g/ml ( 7 ) 10-7 icr responses appear to be masked by marked relaxation, since treatment with PPP potentiated the relaxation.
FIGURE 7. Modification by PPP of the relaxation of coronary and mesenteric arterial strips induced by PGE^ Preparations were contracted with K + (10 to 17 mM). Relaxation induced by 10'* M papaverine was taken as 100%; mean absolute values in control and PPP-treated preparations were 983 ± 195 mg (N = 4) and 1283 ±217 mg (N = 4), respectively, in coronary arteries, and 661 ± 67 mg (N = 7) and 983 ±119 mg (N = 7), respectively, in mesenteric arteries.
The dose-response curve of PGF 2a and E2 in dog cerebral arteries is similar to the curves for coronary, mesenteric and femoral arteries. Similar dose-related contractions have been demonstrated by Strong and Bohr 18 with isolated dog peripheral arteries. In contrast, PGE r induced relaxation relative to that induced by papaverine differed in different arteries. Relaxation of dog as well as human cerebral arteries by PGE! was less than for dog mesenteric arteries. It seems unlikely that the lower degrees of relaxation are associated with the ability of PGE, to contract cerebral arteries to a greater extent, since the relaxing effect of PGE, (5 X 10' to 2 X 10" 6 M) was not significantly influenced by treatment with aspirin or PPP. These were demonstrated in the present study to potentiate or attenuate the response to vasoconstricting PGs, respectively. Further, the difference in PGE,-induced relaxation is not due to the relative unresponsiveness of cerebral arterial strips to vasodilating agents, since NaNO 2 , adenosine and papaverine cause cerebroarterial relaxation to a similar or even greater extent than those of peripheral arteries. 19 ' 20 Contractile responses to PGF 2a and E 2 were not reduced by phentolamine, methysergide and chlorpheniramine, suggesting that alpha-adrenergic, serotonergic and histaminergic H! mechanisms are not involved. These results are consistent with those of Strong and Bohr. 21 Relaxation induced by PGE! was not attenuated by propranolol, atropine, cimetidine and aminophylline, suggesting that beta-adrenergic, cholinergic, histaminergic H 2 and adenosine-related mechanisms are not involved. PPP suppressed the response to PGF 2Q and E 2 in a dose-dependent manner, while this antagonist failed to alter the contractile effect of K + . Specific antagonism of PPP to actions of PGF 2a and E 2 has been demonstrated in isolated rabbit intestine, guinea pig, rat, rabbit and monkey uterus 8 ' 22 and human bronchus. 10 However, the response of human umbilical cord to PGE 2 is not specifically attenuated. 23 The findings obtained in the present study and studies with intestine, uterus and bronchus suggest that PGF 2a and E 2 share the site(s) of action with PPP. However, all mechanisms of action of these PGs on arterial contraction are not necessarily the same, because a PG derivative, 7-oxa-13-prostynoic acid, in concentrations sufficient to reduce the response to PGE 2 , fails to alter the response to PGF 2a . 24 On the other hand, relaxations induced by PGEi were not influenced by PPP, except the relaxation at 10 5 M, which was potentiated, possibly due to an attenuation of the contractile response. It may be concluded that responses to vasoconstricting PGs (PGF 2a , E 2 and Ej except for the contraction induced by low concentrations of PGEi) are specifically antagonized by PPP but the response to vasodilating PGs is not influenced.
Aspirin and indomethacin, PG synthesis inhibitors, in concentrations sufficient to inhibit responses of isolated cerebral arteries to bradykinin 25 potentiated the contractile response to PGF 2a and E 2 but did not influence the relaxing effect of PGEi. Treatment with these concentrations of aspirin failed to alter the contraction induced by K + but attenuated the contractile effect of serotonin. These findings indicate that aspirin and indomethacin specifically potentiate the action of vasoconstricting PGs but not the action of vasodilating PGEj. It has been postulated that probenecid, indomethacin and aspirin interfere with the active transport of PGs across cell membranes of kidney slices, 26 ' " where PGs are metabolized. 28 The potentiation by aspirin as well as indomethacin may be associated with an interference with the metabolism of PGs in arterial smooth muscle cells. Whether the metabolism and the interference by these agents with the metabolism in arteries are observed only with PGF 2a and E 2 but not with PGE! remains to be determined. Further, 15-hydroxyprostaglandin dehydrogenase, which inactivates PGs including E,, 29 is inhibited by aspirin and indomethacin. 30 However, the potentiation of contractile responses to PGF 2a and E 2 may not be related to the inhibition of the enzyme, since the response to PGE! was unaffected. In previous models of mycotic aneurysm, the inflammation attributed to bacterial contamination was probably due to the lead-chromate pigment used.
INJECTION of artificial emboli into the cerebral circulation has often been utilized as a means of producing experimental cerebral infarction. Emboli used have included autologous blood clots, 1 steel ball bearings, 2 psylium seeds, pigmented silicone rubber compounds with and without a coating of bacteria, 3 ' 4 barium-impregnated silicone spheres, 6 and others. These studies usually have reported examinations of the resultant parenchymal lesions but little attention has been given to examination of the arterial lesions produced by the emboli. Molinari and associates, 6 in their report describing experimentally produced cerebral mycotic aneurysms, injected pigmented silicone rubber cylinders coated with Staphylococcus into the cerebral circulation. They noted polymorphonuclear leukocyte invasion of the vasa vasorum which they theorized preceded inflammatory infiltration of the arterial wall followed by dilatation and formation of aneurysms. No controls
